Aurora Cannabis Issues Firm Denial of Second False Acquisition Report Published by Investing.com

Canadian Cannabis Leader Responds to AI-Generated News Article Alleging MedLeaf Therapeutics Buyout

EDMONTON, Alberta — June 19, 2025 — Aurora Cannabis Inc., a leading global medical cannabis company headquartered in Canada, is actively working to dispel persistent false reports regarding corporate transactions it has not made. On June 18, 2025, the company publicly refuted a second inaccurate news article posted on financial news site Investing.com that claimed Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics.

This latest clarification follows another incorrect story—also published the same day—alleging a separate partnership deal between Aurora and MediPharm GmbH in Germany. Both articles were flagged by Aurora as wholly unsubstantiated and misleading.

No Acquisition, No Partnership: Aurora Affirms No Dealings With MedLeaf Therapeutics or MediPharm GmbH

Aurora Cannabis issued a strong statement categorically denying both claims. The company emphasized that it has not initiated any discussions, signed agreements, or made formal filings related to MedLeaf Therapeutics or MediPharm GmbH.

The company was explicit in asserting that it has engaged in no business combination transactions or strategic partnerships with either of the entities mentioned. Furthermore, Aurora confirmed that no communications, filings, or forward-looking disclosures about such arrangements have ever been made, either publicly or privately.

The erroneous claims have prompted concern among stakeholders, investors, and market watchers, many of whom rely on credible news sources for updates on the evolving cannabis industry.

Articles Labeled as AI-Assisted Raise Concerns About Accuracy and Accountability in Digital Financial Reporting

Adding to the controversy is the revelation that the disputed articles on Investing.com were reportedly generated “with the support of AI” and reviewed by an editor. This detail, included in disclaimers attached to the articles, has led Aurora to question the editorial and verification standards currently in place at the publication.

Aurora is now launching an internal investigation to understand the origin and dissemination of the inaccurate information. While artificial intelligence plays an increasing role in content production across industries, Aurora raised red flags about the potential risks of AI-generated financial reporting without proper oversight or fact-checking mechanisms.

The company also reiterated its commitment to corporate transparency and regulatory compliance, noting that any material corporate actions—such as acquisitions or strategic partnerships—will be communicated directly through authorized channels.

MJBizDaily Removes Similar Report on MedLeaf Acquisition Following Aurora’s Rebuttal

In a related development, cannabis industry publication MJBizDaily also initially reported that Aurora had acquired MedLeaf Therapeutics for $215 million. However, shortly after Aurora issued its public denial, the outlet took down the article and redirected its original link to the homepage, signaling a quiet retraction.

This highlights the broader impact that unverified or prematurely published stories can have on corporate reputation, investor behavior, and public perception—particularly in a market as dynamic and sensitive as the cannabis industry.

Aurora Advises Investors to Rely Only on Official Channels for Corporate Updates and Financial Disclosures

In its formal response, Aurora cautioned stakeholders to disregard reports from Investing.com and instead rely on the company’s own channels—including its website and official regulatory filings—for accurate, up-to-date corporate information.

To reinforce its message, Aurora confirmed that it is not in possession of any material non-public information, and it emphasized that it has not made any announcements regarding mergers, acquisitions, or strategic partnerships at this time.

Investors were directed to the company’s most recent financial filings, which include the audited financial statements and management’s discussion and analysis (MD&A) for the fourth quarter and fiscal year ending March 31, 2025. These documents were filed prior to market opening on June 18 and are available through Aurora’s official website.

Ongoing Vigilance Required as AI Tools Proliferate in News Publishing and Market Communications

The episode surrounding Aurora Cannabis and Investing.com underscores the growing intersection between AI-generated content and corporate news, raising questions about editorial responsibility and investor protection.

As AI tools become more deeply embedded in financial journalism, companies and readers alike will need to remain vigilant about distinguishing credible, fact-based reporting from automated or speculative narratives. Aurora’s quick and transparent response may serve as a benchmark for how publicly traded companies can respond decisively to misinformation in the digital age.

OG source Download Article